Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2025-12-25 @ 10:08 PM
Study NCT ID:
NCT01270958
Status:
COMPLETED
Last Update Posted:
2014-08-06
First Post:
2010-08-31
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-08
Start Date Type:
None
Primary Completion Date:
2010-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-02
Completion Date Type:
ACTUAL
First Submit Date:
2010-08-31
First Submit QC Date:
None
Study First Post Date:
2011-01-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-10-28
Results First Submit QC Date:
None
Results First Post Date:
2011-01-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-08-04
Last Update Post Date:
2014-08-06
Last Update Post Date Type:
ESTIMATED